Theodoros Papathanasiou

4PUBLICATIONS
9CO-AUTHORS
Pharmaceutical delivery technologiesGene and molecular therapyWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 04, 2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple Myeloma.

|Apr 13, 2026
Exposure-response analyses for belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma from DREAMM-6 Arm B and DREAMM-7.

Theodoros Papathanasiou, Xi Chen, Fernando Carreno

|Sep 16, 2025
Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.

Patrick Hanafin, Yu Liu Ho, Theodoros Papathanasiou

|Feb 04, 2020
Impact of dose-escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model-based approach.

Theodoros Papathanasiou, Anders Strathe, Henrik Agersø

Pageof 1

Frequent Collaborators

2 joint publications

Yu Liu Ho

2 joint publications

Geraldine Ferron-Brady

1 joint publications

Trine Meldgaard Lund

1 joint publications

Rune Viig Overgaard